Severe Sepsis Caused by Listeria monocytogenes in A Patient Given Monoclonal Antibodies Against CD38 and Proteosome Inhibitor
作者机构：Department of MicrobiologyThe University of Hong KongHong KongChina State Key Laboratory of Emerging Infectious DiseasesThe University of Hong KongHong KongChina Collaborative Innovation Center for Diagnosis and Treatment of Infectious DiseasesThe University of Hong KongHong KongChina
出 版 物：《Infectious Microbes & Diseases》 (感染微生物与疾病（英文）)
年 卷 期：2019年第1卷第1期
页 面：30-31页
学科分类：0710[理学-生物学] 1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
基 金：supported by funding from the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases the Ministry of Education of China
主 题：listeria multiple myeloma daratumumab carfilzomib
摘 要：Introduction Target therapies are widely used for treatment of various kinds of hematological *** the cancer cells that are targeted,share the same markers with the non-cancerous cells of the immunological system,these therapies are often associated with infectious diseases that require the particular type of immune response for *** this article,we report a case of Listeria monocytogenes bacteraemia complicating carfilzomib and daratumumab treatment for multiple *** the best of our knowledge,this is the first case report of listeriosis as a complication of monoclonal antibodies against CD38 and/or proteosome inhibitor therapy.
维普期刊数据库